Abstract
A phenotypic and genotypic analysis of Acinetobacter baumannii was conducted from 2003 to 2008 in Detroit, MI. The incidence of A. baumannii increased from 1.7 to 3.7/1,000 patient days during the study period. Susceptibility to ampicillin-sulbactam and imipenem decreased from ∼90% to ∼40%. Genotyping revealed polyclonality, suggesting either emergence of multiple resistant strains or spread of a common genetic element. The sharp rise mandates major multidisciplinary interventions to optimize management of this multidrugresistant pathogen.
Original language | English (US) |
---|---|
Pages (from-to) | 2235-2238 |
Number of pages | 4 |
Journal | Antimicrobial agents and chemotherapy |
Volume | 54 |
Issue number | 5 |
DOIs | |
State | Published - May 2010 |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases